UTHR — United Therapeutics Corporation
7 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about UTHR (2026-11-04)
- United Therapeutics reported Q3 2026 EPS of $5.71, missing the $6.00 estimate by 4.8%.
- Revenue of $832.5M beat the $781.6M estimate by 6.5%.
- Chairperson & CEO ROTHBLATT MARTINE A sold 9,500 shares at an average price of $596.2248.
| Bluesky | 5 | community |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |